0001243233-24-000002.txt : 20241212 0001243233-24-000002.hdr.sgml : 20241212 20241211185518 ACCESSION NUMBER: 0001243233-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241212 DATE AS OF CHANGE: 20241211 EFFECTIVENESS DATE: 20241212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-531835 FILM NUMBER: 241542737 BUSINESS ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001750284 Olema Pharmaceuticals, Inc. 780 BRANNAN STREET SAN FRANCISCO CA CALIFORNIA 94103 (415) 651-3316 DELAWARE Combithera, Inc. None Corporation true Sean Bohen, M.D., Ph.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Executive Officer Director David C. Myles, Ph.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Executive Officer Shane Kovacs c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Executive Officer Naseem Zojwalla, M.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Executive Officer Yi Larson c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Andrew Rappaport c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Cynthia Butitta c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Cyrus L. Harmon, Ph.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Sandra Horning, M.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Gorjan Hrustanovic, Ph.D. c/o Olema Pharmaceuticals, Inc. San Francisco CA CALIFORNIA 94103 Director Graham Walmsley, M.D., Ph.D. c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Ian Clark c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Scott Garland c/o Olema Pharmaceuticals, Inc. 780 Brannan Street San Francisco CA CALIFORNIA 94103 Director Pharmaceuticals Decline to Disclose 06b false 2024-12-04 false true true true false 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 All States false J.P. Morgan Securities LLC 79 None None 383 Madison Avenue New York NY NEW YORK 10179 All States false Goldman Sachs & Co. LLC 361 None None 200 West Street New York NY NEW YORK 10282 All States false LifeSci Capital LLC 168404 None None 1700 Broadway 40th Floor New York NY NEW YORK 10019 All States false Oppenheimer & Co. Inc. 249 None None 85 Broad Street 23rd Floor New York NY NEW YORK 10004 All States false H.C. Wainright & Co., LLChow 375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 All States false Citigroup Global Markets Inc. 7059 None None 388 Greenwich Street Tower Building New York NY NEW YORK 10013 All States false 249999986 249999225 761 The Total Offering Amount and Total Amount Remaining to be Sold include amounts that may be received by the Issuer upon exercise of pre-funded warrants at an exercise price of $0.0001 per pre-funded warrant. false 26 12500000 0 0 false Olema Pharmaceuticals, Inc. /s/ Shane Kovacs Shane Kovacs Chief Operating and Financial Officer 2024-12-11